Inge H. M. van Loo
Impact in
- Microbiology top 0.5%
- Bacterial Infections and Vaccines
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Viral gastroenteritis research and epidemiology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 4
- Epidemiology 15
- Hepatitis B Virus Studies 4
- Infective Endocarditis Diagnosis and Management 4
- Co-authors
- Frits R. Mooi (3 shared papers)Audrey J. King (2 shared papers)Kees J. Heuvelman (3 shared papers)Gijs T. J. van Well (3 shared papers)Christian J. P. A. Hoebe (24 shared papers)Marjolein van Gent (2 shared papers)Peter Teunis (2 shared papers)Nicole H. T. M. Dukers–Muijrers (21 shared papers)
- Journals
- PLoS ONE (8 papers)Journal of Clinical Microbiology (6 papers)Emerging infectious diseases (3 papers)Sexually Transmitted Diseases (3 papers)Journal of Clinical Virology (2 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Inge H. M. van Loo
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 71
- Microbiology 681
- Infectious Diseases 430
- Epidemiology 607
- Clinical Biochemistry 84
- Endocrinology 57
Countries citing papers authored by Inge H. M. van Loo
This map shows the geographic impact of Inge H. M. van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge H. M. van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge H. M. van Loo more than expected).
Fields of papers citing papers by Inge H. M. van Loo
This network shows the impact of papers produced by Inge H. M. van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge H. M. van Loo. The network helps show where Inge H. M. van Loo may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge H. M. van Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 265 | |
| 2 | 2001 | 178 | |
| 3 | 2007 | 142 | |
| 4 | 2002 | 111 | |
| 5 | 1999 | 80 | |
| 6 | 2014 | 59 | |
| 7 | 2011 | 56 | |
| 8 | 2002 | 46 | |
| 9 | 2017 | 42 | |
| 10 | 2012 | 30 | |
| 11 | 2007 | 29 | |
| 12 | 2011 | 25 | |
| 13 | 2012 | 24 | |
| 14 | 2020 | 22 | |
| 15 | 2009 | 18 | |
| 16 | 2011 | 17 | |
| 17 | 2021 | 13 | |
| 18 | 2018 | 12 | |
| 19 | 2015 | 11 | |
| 20 | 2017 | 10 |
About Inge H. M. van Loo
Inge H. M. van Loo is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Hepatology and Surgery, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (7 papers), Reproductive tract infections research (6 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and Infective Endocarditis Diagnosis and Management (4 papers). The work is most often cited by research in Microbiology (681 citations), Infectious Diseases (430 citations), Epidemiology (607 citations), Clinical Biochemistry (84 citations) and Endocrinology (57 citations). Inge H. M. van Loo has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Frits R. Mooi, Audrey J. King, Kees J. Heuvelman, Frits R. Mooi, Gijs T. J. van Well, Christian J. P. A. Hoebe, Marjolein van Gent, Peter Teunis, Nicole H. T. M. Dukers–Muijrers and Dimitri A. Diavatopoulos. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology, Emerging infectious diseases, Sexually Transmitted Diseases and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.